ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Illumina expands its Billion Cell Atlas program by adding new AI drug developers. The initiative aims to accelerate drug discovery through large-scale cellular analysis. The company partners with AI-driven firms to analyze billions of cells for therapeutic targets.
Tap to vote and see what everyone thinks.
Summary by ByteBrief